Cizzle Biotechnology looking to adapt ELISA assay into being a more general screening tool (LON:CIZ)
Cizzle Biotechnology’s Allan Syms discusses their collaboration with FairJourney Biologics and the company’s main focus over the next 6 months in this exclusive interview with DirectorsTalk.